1
TÍTULO: Sickle cell disease landscape and challenges in the EU the ERN-EuroBloodNet perspective
AUTORES: Pereira, Maria del Mar Manu; Colombatti, Raffaella; Alvarez, Federico; Bartolucci, Pablo; Bento, Celeste; Brunetta, Angelo Loris; Cela, Elena; Christou, Soteroula; Collado, Anna; de Montalembert, Mariane; Dedeken, Laurence; Fenaux, Pierre; Galacteros, Frederic; Glenthoj, Andreas; Valle, Victoria Gutierrez; Kattamis, Antonis; Kunz, Joachim; Lobitz, Stephan; McMahon, Corrina; Pellegrini, Mariangela; Reidel, Sara; Russo, Giovanna; Freire, Miriam Santos; van Beers, Eduard; Kountouris, Petros; Gulbis, Beatrice; ...Mais
PUBLICAÇÃO: 2023, FONTE: LANCET HAEMATOLOGY, VOLUME: 10, NÚMERO: 8
INDEXADO EM: Scopus WOS
2
TÍTULO: Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
AUTORES: Heiblig, Mael; Ferrada, Marcela A.; Koster, Matthew T.; Barba, Thomas; Gerfaud Valentin, Mathieu; Mekinian, Arsene; Coelho, Henrique; Fossard, Gaelle; Barraco, Fiorenza; Galicier, Lionel; Bienvenu, Boris; Hirsch, Pierre; Vial, Guillaume; Boutin, Anne Blandine; Galland, Joris; Le Guenno, Guillaume; Bigot, Adrien; Warrington, Kenneth J.; Kermani, Tanaz A.; Grayson, Peter C.; Patel, Bhavisha A.; Beck, David B.; Jamilloux, Yvan; Fenaux, Pierre; Sujobert, Pierre; ...Mais
PUBLICAÇÃO: 2022, FONTE: BLOOD, VOLUME: 140, NÚMERO: 8
INDEXADO EM: WOS
3
TÍTULO: Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes
AUTORES: Garcia Manero, G; Santini, V; Almeida, A; Platzbecker, U; Jonasova, A; Silverman, LR; Falantes, J; Reda, G; Buccisano, F; Fenaux, P; Buckstein, R; Campelo, MD; Larsen, S; Valcarcel, D; Vyas, P; Giai, V; Oliva, EN; Shortt, J; Niederwieser, D; Mittelman, M; Fianchi, L; La Torre, I; Zhong, JH; Laille, E; de Menezes, DL; Skikne, B; Beach, CL; Giagounidis, A; ...Mais
PUBLICAÇÃO: 2021, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 39, NÚMERO: 13
INDEXADO EM: Scopus WOS
4
TÍTULO: Clinical Efficacy of JAK Inhibitors in Patients with Vexas Syndrome: A Multicenter Retrospective Study
AUTORES: Heiblig, Mael; Ferrada, Marcela A.; Gerfaud Valentin, Mathieu; Barba, Thomas; Mekinian, Arsene; Koster, Matthew; Coelho, Henrique; Fossard, Gaelle; Barraco, Fiorenza; Galicier, Lionel; Bienvenu, Boris; Hirsch, Pierre; Vial, Guillaume; Boutin, Anne Blandine; Le Guenno, Guillaume; Bigot, Adrien; Warrington, Kenneth; Kermani, Tanaz; Jamilloux, Yvan; Grayson, Peter C.; Patel, Bhavisha A.; Beck, David B.; Fenaux, Pierre; Sujobert, Pierre; ...Mais
PUBLICAÇÃO: 2021, FONTE: BLOOD, VOLUME: 138
INDEXADO EM: WOS
5
TÍTULO: Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes  Full Text
AUTORES: Louise de Swart; Simon Crouch; Marlijn Hoeks; Alex Smith; Saskia Langemeijer; Pierre Fenaux; Argiris Symeonidis; Jaroslav Cermak; Eva Hellstrom Lindberg; Reinhard Stauder; Guillermo Sanz; Moshe Mittelman; Mette Skov Holm; Luca Malcovati; Krzysztof Madry; Ulrich Germing; Aurelia Tatic; Aleksandar Savic; Antonio Medina Almeida; Njetocka Gredelj Simec; Agnes Guerci Bresler; Odile Beyne Rauzy; Dominic Culligan; Ioannis Kotsianidis; Raphael Itzykson; Corine van Marrewijk; Nicole Blijlevens; David Bowen; Theo de Witte; ...Mais
PUBLICAÇÃO: 2020, FONTE: HAEMATOLOGICA, VOLUME: 105, NÚMERO: 3
INDEXADO EM: Scopus WOS
6
TÍTULO: Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS  Full Text
AUTORES: Louise de Swart; Alex Smith; Detlef Haase; Pierre Fenaux; Argiris Symeonidis; Jaroslav Cermak; Guillermo Sanz; Reinhard Stauder; Moshe Mittelman; Eva Hellstrom Lindberg; Luca Malcovati; Saskia Langemeijer; Mette Skov Holm; Krzysztof Madry; Ulrich Germing; Antonio Medina Almeida; Aurelia Tatic; Aleksandar Savic; Njetocka Gredelj Simec; Corine van Marrewijk; Agnes Guerci Bresler; Laurence Sanhes; Elisa Luno; Dominic Culligan; Odile Beyne Rauzy; Sonja Burgstaller; Nicole Blijlevens; David Bowen; Theo de Witte; ...Mais
PUBLICAÇÃO: 2018, FONTE: LEUKEMIA RESEARCH, VOLUME: 67
INDEXADO EM: Scopus WOS
7
TÍTULO: Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial
AUTORES: Antonio Almeida; Pierre Fenaux; Guillermo Garcia Manero; Stuart L Goldberg; Stefanie Groepper; Anna Jonasova; Norbert Vey; Carmen Castaneda; Jianhua H Zhong; Beach, CL; Valeria Santini;
PUBLICAÇÃO: 2018, FONTE: LEUKEMIA & LYMPHOMA, VOLUME: 59, NÚMERO: 9
INDEXADO EM: WOS
8
TÍTULO: IMPACT OF GENE MUTATIONS ON RESPONSE TO LENALIDOMIDE AND OS IN LOWER-RISK NON-DEL(5Q) MDS PATIENTS INELIGIBLE/REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)  Full Text
AUTORES: Santini, V; Fenaux, P; Giagounidis, A; Platzbecker, U; Almeida, A; List, AF; Zhong, J; Wu, C; Mavrommatis, K; Beach, CL; MacBeth, KJ;
PUBLICAÇÃO: 2017, FONTE: 14th International Symposium on Myelodysplastic Syndromes (MDS) in LEUKEMIA RESEARCH, VOLUME: 55
INDEXADO EM: WOS
9
TÍTULO: IMPACT OF GENE MUTATIONS ON RESPONSE TO LENALIDOMIDE AND OS IN LOWER-RISK NON-DEL(5Q) MDS PATIENTS INELIGIBLE/REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)  Full Text
AUTORES: Santini, V; Fenaux, P; Giagounidis, A; Platzbecker, U; Almeida, A; List, AF; Zhong, J; Wu, C; Mavrommatis, K; Beach, CL; MacBeth, KJ;
PUBLICAÇÃO: 2017, FONTE: 46th Congress of the Italian-Society-of-Hematology in HAEMATOLOGICA, VOLUME: 102
INDEXADO EM: WOS
10
TÍTULO: Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents
AUTORES: Valeria Santini; Antonio Almeida; Aristoteles Giagounidis; Stefanie Groepper; Anna Jonasova; Norbert Vey; Ghulam J Mufti; Rena Buckstein; Moshe Mittelman; Uwe Platzbecker; Ofer Shpilberg; Ron Ram; Consuelo del Canizo; Norbert Gattermann; Keiya Ozawa; Alberto Risueno; Kyle J MacBeth; Jianhua H Zhong; Francis Seguy; Albert Hoenekopp; Beach, CL; Pierre Fenaux; ...Mais
PUBLICAÇÃO: 2016, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, NÚMERO: 25
INDEXADO EM: Scopus WOS CrossRef